Effect of the modified Mediterranean diet for prevention of metabolic syndrome in patients undergoing liver transplantatio

Not Applicable

• Conditions: Condition 1: Metabolic Syndrome. Condition 2: Metabolic Syndrome. Condition 3: Metabolic Syndrome. Condition 4: Metabolic Syndrome. Condition 5: Metabolic Syndrome.; Pure hyperglyceridaemia; Essential (primary) hypertension; Elevated blood glucose level; Abnormal weight gain; Lipoprotein deficiency

• Registration Number: IRCT2015012720841N1
• Lead Sponsor: Vice-Chancellery of Research and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

age over 18 exclusion criteria: age under 18; patient with any malignancy; multivisceral transplant; malignancy during study; Patients who do not want to cooperate

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood Pressure. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: By a sphygmomanometer.;Weight. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: Iranian Rasa company scale.;Waist circumference. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: Meters of fabric.;Blood suger tests. Timepoint: Every 4 weeks till 16 weeks. Method of measurement: by an automated clinical chemistry analyzer.;Lipid profile ( TG,CHOL,HDL-C,LDL-C ). Timepoint: Every 4 weeks till 16 weeks. Method of measurement: By an automated clinical chemistry analyzer.